Skip to main content

Pathology of Other Skin Cancer

  • Chapter
  • First Online:
Skin Cancer

Abstract

In this chapter, we will focus on two malignant skin tumors: Merkel cell carcinoma and dermatofibrosarcoma protuberans (DFSP). The histogenesis, epidemiology, pathology, clinical features, diagnosis, and therapy of both tumors will be illustrated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Darier J, Ferrand M. Dermatofibromes progressifs et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiliga. 1924;5:545–62.

    Google Scholar 

  2. Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997;37:438–44.

    Article  PubMed  CAS  Google Scholar 

  3. Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol. 2004;30(3):341–5.

    Article  PubMed  CAS  Google Scholar 

  4. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995;164(1):129–34.

    Article  PubMed  CAS  Google Scholar 

  5. Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355–74.

    Article  PubMed  Google Scholar 

  6. Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56(6):968–73. Epub 2006 Dec 1.

    Article  PubMed  Google Scholar 

  7. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans: a study of 115 cases. Cancer. 1962;15:717–25.

    Article  PubMed  CAS  Google Scholar 

  8. McKee PH, Fletcher CD. Dermatofibrosarcoma protuberans in infancy and childhood. J Cutan Pathol. 1991;18:241–6.

    Article  PubMed  CAS  Google Scholar 

  9. Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000;88(12):2711–20.

    Article  PubMed  CAS  Google Scholar 

  10. Abeloff MD. Abeloff’s clinical oncology. 4th ed. Philadelphia: Elsevier; 2008: Ch 74; Dupree WB, Langloss JW, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural and immunohistochemical study. Am J Surg Pathol. 1985;9:630–9.

    Google Scholar 

  11. Klijanienko J, Caillaud JM, Lagacé R. Fine-needle aspiration of primary and recurrent dermatofibrosarcoma protuberans. Diagn Cytopathol. 2004;30(4):261–5; Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol. 1997;37(3 Pt 1):438–44.

    Google Scholar 

  12. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993;15(5):429–34.

    Article  PubMed  CAS  Google Scholar 

  13. Pedeutour F, Simon MP, Minoletti F, et al. Ring 22 chromosomes in dermatofibrosarcoma protuberans are low level amplifiers of chromosome 17 and 22l sequences. Cancer Res. 1995;55:2400–3.

    PubMed  CAS  Google Scholar 

  14. Bridge JA, Neff JR, Sanberg AA. Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet. 1990;49:199–202.

    Article  PubMed  CAS  Google Scholar 

  15. No authors listed. Soft tissue sarcoma. In: Greene PL, Page DL, Fleming ID, editors. AJCC cancer staging manual. 6th ed. New York: Verlag; 2002. pp. 193–200.

    Google Scholar 

  16. Arnaud EJ, Perrault M, Revol M, Servant JM, Banzet P. Surgical treatment of dermatofibrosarcoma protuberans. Plast Reconstr Surg. 1997;100(4):884–95.

    PubMed  CAS  Google Scholar 

  17. Paradisi A, Abeni D, Rusciani A, Cigna E, Wolter M, Scuderi N, et al. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev. 2008;34(8):728–36.

    Article  PubMed  CAS  Google Scholar 

  18. Briggaman RA, Wheeler CEJ. The epidermal-dermal junction. J Invest Dermatol. 1975;65:71–84.

    Article  PubMed  CAS  Google Scholar 

  19. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107–10.

    Article  PubMed  CAS  Google Scholar 

  20. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42:2311–21.

    Article  PubMed  CAS  Google Scholar 

  21. Johannessen JV, Gould VE. Neuroendocrine skin carcinoma associated with calcitonin production: a Merkel cell carcinoma? Hum Pathol. 1980;11:586–8.

    PubMed  CAS  Google Scholar 

  22. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1–4.

    Article  PubMed  Google Scholar 

  23. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:315–23.

    Article  PubMed  CAS  Google Scholar 

  24. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000;18:2493–9.

    PubMed  CAS  Google Scholar 

  25. Koljonen V, Bohling T, Granhroth G, Tukiainen E. Merkel cell carcinoma: a clinicopathiological study of 34 patients. Eur J Surg Oncol. 2003;29:607–10.

    Article  PubMed  CAS  Google Scholar 

  26. Connelly TJ, Cribier B, Brown TJ, Yanguas I. Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases. Dermatol Surg. 2000;26:853–6.

    Article  PubMed  CAS  Google Scholar 

  27. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg. 1995;21:669–83.

    PubMed  CAS  Google Scholar 

  28. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995;8:384–8.

    PubMed  CAS  Google Scholar 

  29. Leong AS, Phillips GE, Pieterse AS, Milios J. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology. 1986;18:393–9.

    Article  PubMed  CAS  Google Scholar 

  30. Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cacquyt V, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer. 2002;101:137–45.

    Article  PubMed  Google Scholar 

  31. Larramendy ML, Koljonen V, Bohling T, Tukiainen E, Knuutila S. Recurrent DNA copy number changes revealed by comparative genomic hybridization in primary Merkel cell carcinomas. Mod Pathol. 2004;17:561–7.

    Article  PubMed  CAS  Google Scholar 

  32. Linjawi A, Jamison WB, Meterissian S. Merkel cell carcinoma: important aspects of diagnosis and management. Am Surg. 2001;67:943–7.

    PubMed  CAS  Google Scholar 

  33. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg. 1991;126:1514–9.

    Article  PubMed  CAS  Google Scholar 

  34. Brisset AE, Olsen KD, Kasperbauer JL, Lewis JE, Goellner JR, Spotts BE, et al. Strome se: Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck. 2002;24:982–8.

    Article  Google Scholar 

  35. Kolsonen V. Merkel cell carcinoma. World J Surg Oncol 2006;4:7

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfonso Baldi .

Editor information

Editors and Affiliations

Glossary

CD34

Glycoproteins found on immature hematopoietic cells and endothelial cells

Cytokeratin

Any of a class of fibrous proteins that are intermediate filaments present usually in pairs chiefly in epithelial cells and that are sometimes used as markers to identify malignancies of epithelial origin

Nerve growth factor receptor

Any of a family of plasma membrane integral proteins that bind nerve growth factors

Neuroendocrine tumor

A tumor that forms from cells that release hormones in response to a signal from the nervous system

Soft tissue sarcoma

A malignant tumor that begins in the muscle, fat, fibrous tissue, blood vessels, or other “soft” supporting tissues of the body

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Baldi, F., Fortuño-Mar, A., Bianchi, A., D’Avino, A., Baldi, A. (2014). Pathology of Other Skin Cancer. In: Baldi, A., Pasquali, P., Spugnini, E. (eds) Skin Cancer. Current Clinical Pathology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-7357-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7357-2_8

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4614-7356-5

  • Online ISBN: 978-1-4614-7357-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics